Skip to the page

Data / Form D filings / PhenoVista BioSciences, Inc.

PhenoVista BioSciences, Inc.: Form D filing

PhenoVista BioSciences, Inc., a biotechnology company in San Diego, CA, filed a Form D with the SEC in 2023. The latest, on January 11, 2023, reports $3 million sold of a $3 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
6195 CORNERSTONE COURT EAST, SUITE #114, San Diego, CA, 92121
Phone
(858) 465-9175
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1961831

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 11, 2023New notice$3,000,000$3,000,0001Dec 7, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Brian G. ConnExecutive Officer
James G. EvansExecutive Officer, Director
Anthony G. EssexExecutive Officer, Director

Other biotechnology companies in California that filed recently

Every Form D from the week of Jan 9, 2023 · All recent filings in California · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what PhenoVista BioSciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.